Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 70.25

+0.1%

Nov 6 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (422)	11/6/2003 1:37:40 PM
From: Jibacoa	Read Replies (1) of 3722

SGP Continues on the doldrums.<g> It seems it may retest its August 22 L of 14.16 in spite of all the changes that its CEO Fred Hassan has been making on his team since he took over last April.<g> forbes.com The stock has previously closed its August 22 downgap and needs to trade above its September 18 H of 16.82 in order to improve its chart pattern.<g> siliconinvestor.com The estimated earnings for the current year remain at $0.38/share and $0.35/share for 2004, but IMHO it may be good to keep SGP in mind for a possible buy after the tax selling season is over.(The cash flow remains around $1.68/share) bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next